Annual Income Statements for Lineage
This table shows Lineage's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.
Quarterly Income Statements for Lineage
This table shows Lineage's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.
Metric |
|
Q2 2023 |
Q3 2023 |
Q2 2024 |
Q3 2024 |
Q1 2025 |
Net Income / (Loss) Attributable to Common Shareholders |
|
-5.00 |
-39 |
-68 |
-485 |
0.00 |
Consolidated Net Income / (Loss) |
|
-8.00 |
-50 |
-80 |
-543 |
0.00 |
Net Income / (Loss) Continuing Operations |
|
-8.00 |
-50 |
-80 |
-543 |
0.00 |
Total Pre-Tax Income |
|
-8.00 |
-55 |
-73 |
-588 |
8.00 |
Total Revenue |
|
-3.00 |
-5.00 |
2.00 |
8.00 |
16 |
Net Interest Income / (Expense) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Total Interest Income |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Total Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Total Non-Interest Income |
|
-3.00 |
-5.00 |
2.00 |
8.00 |
16 |
Net Realized & Unrealized Capital Gains on Investments |
|
-3.00 |
-5.00 |
2.00 |
8.00 |
16 |
Total Non-Interest Expense |
|
-111 |
-97 |
-74 |
515 |
-56 |
Other Operating Expenses |
|
1,029 |
1,021 |
1,018 |
1,040 |
1,030 |
Depreciation Expense |
|
136 |
137 |
164 |
156 |
158 |
Amortization Expense |
|
52 |
51 |
55 |
54 |
54 |
Impairment Charge |
|
3.00 |
4.00 |
15 |
8.00 |
-21 |
Restructuring Charge |
|
15 |
19 |
12 |
592 |
15 |
Other Special Charges |
|
-1,346 |
-1,329 |
-1,338 |
-1,335 |
-1,292 |
Nonoperating Income / (Expense), net |
|
-116 |
-147 |
-149 |
-81 |
-64 |
Income Tax Expense |
|
0.00 |
-5.00 |
7.00 |
-45 |
8.00 |
Net Income / (Loss) Attributable to Noncontrolling Interest |
|
-3.00 |
-11 |
-12 |
-58 |
0.00 |
Basic Earnings per Share |
|
($0.08) |
($0.26) |
($0.46) |
($2.44) |
$0.01 |
Weighted Average Basic Shares Outstanding |
|
162M |
162M |
162M |
210M |
228M |
Diluted Earnings per Share |
|
($0.08) |
($0.26) |
($0.46) |
($2.44) |
$0.01 |
Weighted Average Diluted Shares Outstanding |
|
162M |
162M |
162M |
210M |
228M |
Weighted Average Basic & Diluted Shares Outstanding |
|
- |
- |
227.69M |
228.41M |
228.59M |
Annual Cash Flow Statements for Lineage
This table details how cash moves in and out of Lineage's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.
Metric |
2022 |
2023 |
2024 |
Net Change in Cash & Equivalents |
-38 |
-131 |
104 |
Net Cash From Operating Activities |
501 |
796 |
703 |
Net Cash From Continuing Operating Activities |
501 |
796 |
703 |
Net Income / (Loss) Continuing Operations |
-76 |
-96 |
-751 |
Consolidated Net Income / (Loss) |
-76 |
-96 |
-751 |
Provision For Loan Losses |
5.00 |
6.00 |
5.00 |
Depreciation Expense |
678 |
760 |
876 |
Amortization Expense |
17 |
21 |
19 |
Non-Cash Adjustments to Reconcile Net Income |
2.00 |
3.00 |
609 |
Changes in Operating Assets and Liabilities, net |
-125 |
102 |
-55 |
Net Cash From Investing Activities |
-2,369 |
-1,066 |
-919 |
Net Cash From Continuing Investing Activities |
-2,369 |
-1,066 |
-919 |
Purchase of Property, Leasehold Improvements and Equipment |
-813 |
-766 |
-691 |
Purchase of Investment Securities |
-1,652 |
-319 |
-355 |
Sale and/or Maturity of Investments |
3.00 |
19 |
127 |
Net Cash From Financing Activities |
1,840 |
136 |
320 |
Net Cash From Continuing Financing Activities |
1,829 |
136 |
320 |
Issuance of Debt |
3,411 |
1,431 |
6,593 |
Issuance of Common Equity |
0.00 |
-6.00 |
4,879 |
Repayment of Debt |
-2,255 |
-1,312 |
-10,624 |
Repurchase of Common Equity |
0.00 |
-12 |
-42 |
Payment of Dividends |
-191 |
-46 |
-234 |
Other Financing Activities, Net |
864 |
81 |
-252 |
Effect of Exchange Rate Changes |
-10 |
3.00 |
0.00 |
Cash Interest Paid |
354 |
594 |
523 |
Cash Income Taxes Paid |
74 |
31 |
36 |
Quarterly Cash Flow Statements for Lineage
This table details how cash moves in and out of Lineage's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.
Metric |
|
Q3 2023 |
Q4 2023 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Net Change in Cash & Equivalents |
|
-29 |
-41 |
336 |
-237 |
22 |
Net Cash From Operating Activities |
|
229 |
231 |
186 |
257 |
139 |
Net Cash From Continuing Operating Activities |
|
229 |
231 |
186 |
257 |
139 |
Net Income / (Loss) Continuing Operations |
|
-50 |
-57 |
-543 |
-80 |
0.00 |
Consolidated Net Income / (Loss) |
|
-50 |
-57 |
-543 |
-80 |
0.00 |
Provision For Loan Losses |
|
2.00 |
2.00 |
1.00 |
2.00 |
1.00 |
Depreciation Expense |
|
188 |
203 |
210 |
236 |
212 |
Amortization Expense |
|
5.00 |
5.00 |
4.00 |
3.00 |
2.00 |
Non-Cash Adjustments to Reconcile Net Income |
|
21 |
-3.00 |
493 |
97 |
24 |
Changes in Operating Assets and Liabilities, net |
|
63 |
81 |
21 |
-1.00 |
-100 |
Net Cash From Investing Activities |
|
-191 |
-421 |
-138 |
-383 |
-138 |
Net Cash From Continuing Investing Activities |
|
-191 |
-421 |
-138 |
-383 |
-138 |
Purchase of Property, Leasehold Improvements and Equipment |
|
-177 |
-161 |
-153 |
-205 |
-151 |
Acquisitions |
|
- |
-1.00 |
3.00 |
- |
0.00 |
Purchase of Investment Securities |
|
-38 |
-265 |
-39 |
-246 |
-6.00 |
Sale and/or Maturity of Investments |
|
24 |
6.00 |
51 |
71 |
19 |
Net Cash From Financing Activities |
|
-64 |
146 |
284 |
-108 |
21 |
Net Cash From Continuing Financing Activities |
|
-64 |
146 |
284 |
-108 |
21 |
Issuance of Debt |
|
346 |
606 |
1,446 |
308 |
582 |
Repayment of Debt |
|
-395 |
-427 |
-5,883 |
-273 |
-423 |
Repurchase of Common Equity |
|
- |
-9.00 |
- |
-17 |
0.00 |
Payment of Dividends |
|
- |
-46 |
- |
-145 |
-134 |
Other Financing Activities, Net |
|
127 |
28 |
-158 |
19 |
-4.00 |
Effect of Exchange Rate Changes |
|
-3.00 |
3.00 |
4.00 |
-3.00 |
0.00 |
Cash Interest Paid |
|
163 |
148 |
135 |
69 |
86 |
Cash Income Taxes Paid |
|
-10 |
-1.00 |
2.00 |
6.00 |
1.00 |
Annual Balance Sheets for Lineage
This table presents Lineage's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.
Metric |
2023 |
2024 |
Total Assets |
18,871 |
18,661 |
Cash and Due from Banks |
68 |
173 |
Restricted Cash |
3.00 |
2.00 |
Trading Account Securities |
113 |
124 |
Loans and Leases, Net of Allowance |
0.00 |
0.00 |
Premises and Equipment, Net |
10,571 |
10,627 |
Goodwill |
3,394 |
3,338 |
Intangible Assets |
1,280 |
1,127 |
Other Assets |
3,442 |
3,270 |
Total Liabilities & Shareholders' Equity |
18,871 |
18,661 |
Total Liabilities |
12,849 |
8,967 |
Short-Term Debt |
134 |
190 |
Other Short-Term Payables |
1,137 |
1,303 |
Long-Term Debt |
10,263 |
6,155 |
Other Long-Term Liabilities |
1,330 |
1,319 |
Commitments & Contingencies |
0.00 |
0.00 |
Redeemable Noncontrolling Interest |
349 |
43 |
Total Equity & Noncontrolling Interests |
5,673 |
9,651 |
Total Preferred & Common Equity |
5,051 |
8,638 |
Preferred Stock |
1.00 |
0.00 |
Total Common Equity |
5,050 |
8,638 |
Common Stock |
5,963 |
10,766 |
Retained Earnings |
-879 |
-1,855 |
Accumulated Other Comprehensive Income / (Loss) |
-34 |
-273 |
Noncontrolling Interest |
622 |
1,013 |
Quarterly Balance Sheets for Lineage
This table presents Lineage's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.
Metric |
Q2 2024 |
Q3 2024 |
Q1 2025 |
Total Assets |
18,756 |
19,256 |
18,768 |
Cash and Due from Banks |
73 |
409 |
197 |
Trading Account Securities |
123 |
120 |
128 |
Loans and Leases, Net of Allowance |
0.00 |
0.00 |
0.00 |
Premises and Equipment, Net |
10,491 |
11,324 |
10,644 |
Goodwill |
3,361 |
3,444 |
3,379 |
Intangible Assets |
1,218 |
1,221 |
1,116 |
Other Assets |
3,487 |
2,735 |
3,304 |
Total Liabilities & Shareholders' Equity |
18,756 |
19,256 |
18,768 |
Total Liabilities |
13,002 |
9,134 |
9,122 |
Short-Term Debt |
50 |
136 |
189 |
Other Short-Term Payables |
1,172 |
1,359 |
1,132 |
Long-Term Debt |
10,593 |
4,955 |
5,130 |
Other Long-Term Liabilities |
1,187 |
2,684 |
2,602 |
Commitments & Contingencies |
0.00 |
0.00 |
0.00 |
Redeemable Noncontrolling Interest |
262 |
39 |
41 |
Total Equity & Noncontrolling Interests |
5,492 |
10,083 |
9,605 |
Total Preferred & Common Equity |
4,878 |
9,026 |
8,586 |
Total Common Equity |
4,877 |
9,026 |
8,586 |
Common Stock |
5,983 |
10,746 |
10,793 |
Retained Earnings |
-987 |
-1,662 |
-1,976 |
Accumulated Other Comprehensive Income / (Loss) |
-119 |
-58 |
-231 |
Noncontrolling Interest |
614 |
1,057 |
1,019 |
Annual Metrics And Ratios for Lineage
This table displays calculated financial ratios and metrics derived from Lineage's official financial filings.
Metric |
2022 |
2023 |
2024 |
Growth Metrics |
- |
- |
- |
Revenue Growth |
0.00% |
118.18% |
-1,150.00% |
EBITDA Growth |
0.00% |
21.96% |
-58.41% |
EBIT Growth |
0.00% |
46.18% |
-200.25% |
NOPAT Growth |
0.00% |
46.18% |
-200.25% |
Net Income Growth |
0.00% |
-26.32% |
-682.29% |
EPS Growth |
0.00% |
-43.14% |
-406.85% |
Operating Cash Flow Growth |
0.00% |
58.88% |
-11.68% |
Free Cash Flow Firm Growth |
0.00% |
0.00% |
100.61% |
Invested Capital Growth |
0.00% |
0.00% |
-2.31% |
Revenue Q/Q Growth |
0.00% |
0.00% |
0.00% |
EBITDA Q/Q Growth |
0.00% |
0.00% |
0.00% |
EBIT Q/Q Growth |
0.00% |
0.00% |
0.00% |
NOPAT Q/Q Growth |
0.00% |
0.00% |
0.00% |
Net Income Q/Q Growth |
0.00% |
0.00% |
0.00% |
EPS Q/Q Growth |
0.00% |
0.00% |
0.00% |
Operating Cash Flow Q/Q Growth |
0.00% |
0.00% |
0.00% |
Free Cash Flow Firm Q/Q Growth |
0.00% |
0.00% |
0.00% |
Invested Capital Q/Q Growth |
0.00% |
0.00% |
0.00% |
Profitability Metrics |
- |
- |
- |
EBITDA Margin |
0.00% |
29,575.00% |
0.00% |
EBIT Margin |
0.00% |
10,050.00% |
0.00% |
Profit (Net Income) Margin |
0.00% |
-2,400.00% |
0.00% |
Tax Burden Percent |
108.57% |
87.27% |
89.40% |
Interest Burden Percent |
-25.45% |
-27.36% |
208.44% |
Effective Tax Rate |
0.00% |
0.00% |
0.00% |
Return on Invested Capital (ROIC) |
0.00% |
3.43% |
0.00% |
ROIC Less NNEP Spread (ROIC-NNEP) |
0.00% |
-3.83% |
0.00% |
Return on Net Nonoperating Assets (RNNOA) |
0.00% |
-6.62% |
0.00% |
Return on Equity (ROE) |
0.00% |
-3.19% |
-9.56% |
Cash Return on Invested Capital (CROIC) |
0.00% |
-196.57% |
0.60% |
Operating Return on Assets (OROA) |
0.00% |
2.13% |
0.00% |
Return on Assets (ROA) |
0.00% |
-0.51% |
0.00% |
Return on Common Equity (ROCE) |
0.00% |
-2.67% |
-8.32% |
Return on Equity Simple (ROE_SIMPLE) |
0.00% |
-1.90% |
-8.69% |
Net Operating Profit after Tax (NOPAT) |
193 |
281 |
-282 |
NOPAT Margin |
0.00% |
7,035.00% |
0.00% |
Net Nonoperating Expense Percent (NNEP) |
0.00% |
7.26% |
5.60% |
SG&A Expenses to Revenue |
0.00% |
0.00% |
0.00% |
Operating Expenses to Revenue |
0.00% |
-9,950.00% |
0.00% |
Earnings before Interest and Taxes (EBIT) |
275 |
402 |
-403 |
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
970 |
1,183 |
492 |
Valuation Ratios |
- |
- |
- |
Price to Book Value (P/BV) |
0.00 |
0.88 |
1.55 |
Price to Tangible Book Value (P/TBV) |
0.00 |
11.80 |
3.21 |
Price to Revenue (P/Rev) |
0.00 |
1,109.20 |
0.00 |
Price to Earnings (P/E) |
0.00 |
0.00 |
0.00 |
Dividend Yield |
0.00% |
0.00% |
1.55% |
Earnings Yield |
0.00% |
0.00% |
0.00% |
Enterprise Value to Invested Capital (EV/IC) |
0.00 |
0.96 |
1.28 |
Enterprise Value to Revenue (EV/Rev) |
0.00 |
3,933.70 |
0.00 |
Enterprise Value to EBITDA (EV/EBITDA) |
0.00 |
13.30 |
41.88 |
Enterprise Value to EBIT (EV/EBIT) |
0.00 |
39.14 |
0.00 |
Enterprise Value to NOPAT (EV/NOPAT) |
0.00 |
55.92 |
0.00 |
Enterprise Value to Operating Cash Flow (EV/OCF) |
0.00 |
19.77 |
29.31 |
Enterprise Value to Free Cash Flow (EV/FCFF) |
0.00 |
0.00 |
210.46 |
Leverage & Solvency |
- |
- |
- |
Debt to Equity |
0.00 |
1.73 |
0.65 |
Long-Term Debt to Equity |
0.00 |
1.70 |
0.63 |
Financial Leverage |
0.00 |
1.73 |
1.07 |
Leverage Ratio |
0.00 |
3.13 |
2.39 |
Compound Leverage Factor |
0.00 |
-0.86 |
4.98 |
Debt to Total Capital |
0.00% |
63.32% |
39.56% |
Short-Term Debt to Total Capital |
0.00% |
0.82% |
1.18% |
Long-Term Debt to Total Capital |
0.00% |
62.51% |
38.38% |
Preferred Equity to Total Capital |
0.00% |
0.01% |
0.00% |
Noncontrolling Interests to Total Capital |
0.00% |
5.91% |
6.58% |
Common Equity to Total Capital |
0.00% |
30.76% |
53.86% |
Debt to EBITDA |
0.00 |
8.79 |
12.90 |
Net Debt to EBITDA |
0.00 |
8.73 |
12.54 |
Long-Term Debt to EBITDA |
0.00 |
8.68 |
12.51 |
Debt to NOPAT |
0.00 |
36.95 |
-22.49 |
Net Debt to NOPAT |
0.00 |
36.70 |
-21.87 |
Long-Term Debt to NOPAT |
0.00 |
36.47 |
-21.82 |
Noncontrolling Interest Sharing Ratio |
0.00% |
16.14% |
12.90% |
Liquidity Ratios |
- |
- |
- |
Cash Flow Metrics |
- |
- |
- |
Free Cash Flow to Firm (FCFF) |
0.00 |
-16,138 |
98 |
Operating Cash Flow to CapEx |
61.62% |
103.92% |
101.74% |
Free Cash Flow to Firm to Interest Expense |
0.00 |
0.00 |
0.00 |
Operating Cash Flow to Interest Expense |
0.00 |
0.00 |
0.00 |
Operating Cash Flow Less CapEx to Interest Expense |
0.00 |
0.00 |
0.00 |
Efficiency Ratios |
- |
- |
- |
Asset Turnover |
0.00 |
0.00 |
0.00 |
Fixed Asset Turnover |
0.00 |
0.00 |
0.00 |
Capital & Investment Metrics |
- |
- |
- |
Invested Capital |
0.00 |
16,419 |
16,039 |
Invested Capital Turnover |
0.00 |
0.00 |
0.00 |
Increase / (Decrease) in Invested Capital |
0.00 |
16,419 |
-380 |
Enterprise Value (EV) |
0.00 |
15,735 |
20,604 |
Market Capitalization |
4,437 |
4,437 |
13,378 |
Book Value per Share |
$0.00 |
$31.17 |
$37.82 |
Tangible Book Value per Share |
$0.00 |
$2.32 |
$18.27 |
Total Capital |
0.00 |
16,419 |
16,039 |
Total Debt |
0.00 |
10,397 |
6,345 |
Total Long-Term Debt |
0.00 |
10,263 |
6,155 |
Net Debt |
0.00 |
10,326 |
6,170 |
Capital Expenditures (CapEx) |
813 |
766 |
691 |
Net Nonoperating Expense (NNE) |
269 |
377 |
469 |
Net Nonoperating Obligations (NNO) |
0.00 |
10,397 |
6,345 |
Total Depreciation and Amortization (D&A) |
695 |
781 |
895 |
Earnings Adjustments |
- |
- |
- |
Adjusted Basic Earnings per Share |
$0.00 |
$0.00 |
($3.70) |
Adjusted Weighted Average Basic Shares Outstanding |
0.00 |
0.00 |
191M |
Adjusted Diluted Earnings per Share |
$0.00 |
$0.00 |
($3.70) |
Adjusted Weighted Average Diluted Shares Outstanding |
0.00 |
0.00 |
191M |
Adjusted Basic & Diluted Earnings per Share |
$0.00 |
$0.00 |
$0.00 |
Adjusted Weighted Average Basic & Diluted Shares Outstanding |
0.00 |
0.00 |
228.20M |
Normalized Net Operating Profit after Tax (NOPAT) |
-3,200 |
-3,394 |
-3,525 |
Normalized NOPAT Margin |
0.00% |
-84,840.00% |
0.00% |
Pre Tax Income Margin |
0.00% |
-2,750.00% |
0.00% |
Debt Service Ratios |
- |
- |
- |
EBIT to Interest Expense |
0.00 |
0.00 |
0.00 |
NOPAT to Interest Expense |
0.00 |
0.00 |
0.00 |
EBIT Less CapEx to Interest Expense |
0.00 |
0.00 |
0.00 |
NOPAT Less CapEx to Interest Expense |
0.00 |
0.00 |
0.00 |
Payout Ratios |
- |
- |
- |
Dividend Payout Ratio |
-251.32% |
-47.92% |
-31.16% |
Augmented Payout Ratio |
-251.32% |
-60.42% |
-36.75% |
Quarterly Metrics And Ratios for Lineage
This table displays calculated financial ratios and metrics derived from Lineage's official financial filings.
Metric |
|
Q2 2023 |
Q3 2023 |
Q2 2024 |
Q3 2024 |
Q1 2025 |
Growth Metrics |
|
- |
- |
- |
- |
- |
Revenue Growth |
|
0.00% |
0.00% |
166.67% |
260.00% |
188.89% |
EBITDA Growth |
|
0.00% |
0.00% |
-0.34% |
-202.81% |
-4.67% |
EBIT Growth |
|
0.00% |
0.00% |
-29.63% |
-651.09% |
-13.25% |
NOPAT Growth |
|
0.00% |
0.00% |
-29.63% |
-651.09% |
-100.00% |
Net Income Growth |
|
0.00% |
0.00% |
-900.00% |
-986.00% |
100.00% |
EPS Growth |
|
0.00% |
0.00% |
-475.00% |
-838.46% |
103.57% |
Operating Cash Flow Growth |
|
0.00% |
0.00% |
0.00% |
-18.78% |
32.38% |
Free Cash Flow Firm Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Invested Capital Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Revenue Q/Q Growth |
|
0.00% |
-66.67% |
0.00% |
300.00% |
0.00% |
EBITDA Q/Q Growth |
|
0.00% |
-3.72% |
0.00% |
-199.32% |
0.00% |
EBIT Q/Q Growth |
|
0.00% |
-14.81% |
0.00% |
-767.11% |
0.00% |
NOPAT Q/Q Growth |
|
0.00% |
-14.81% |
0.00% |
-767.11% |
0.00% |
Net Income Q/Q Growth |
|
0.00% |
-525.00% |
0.00% |
-578.75% |
0.00% |
EPS Q/Q Growth |
|
0.00% |
-225.00% |
0.00% |
-430.43% |
0.00% |
Operating Cash Flow Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
-45.91% |
Free Cash Flow Firm Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
4.75% |
0.00% |
Invested Capital Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-7.22% |
0.00% |
Profitability Metrics |
|
- |
- |
- |
- |
- |
EBITDA Margin |
|
0.00% |
0.00% |
14,750.00% |
-3,662.50% |
1,787.50% |
EBIT Margin |
|
0.00% |
0.00% |
3,800.00% |
-6,337.50% |
450.00% |
Profit (Net Income) Margin |
|
0.00% |
0.00% |
-4,000.00% |
-6,787.50% |
0.00% |
Tax Burden Percent |
|
100.00% |
90.91% |
109.59% |
92.35% |
0.00% |
Interest Burden Percent |
|
-7.41% |
-59.78% |
-96.05% |
115.98% |
11.11% |
Effective Tax Rate |
|
0.00% |
0.00% |
0.00% |
0.00% |
100.00% |
Return on Invested Capital (ROIC) |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
ROIC Less NNEP Spread (ROIC-NNEP) |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Return on Net Nonoperating Assets (RNNOA) |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Return on Equity (ROE) |
|
0.00% |
0.00% |
0.00% |
0.00% |
-7.29% |
Cash Return on Invested Capital (CROIC) |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Operating Return on Assets (OROA) |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Return on Assets (ROA) |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Return on Common Equity (ROCE) |
|
0.00% |
0.00% |
0.00% |
0.00% |
-6.49% |
Return on Equity Simple (ROE_SIMPLE) |
|
0.00% |
0.00% |
0.00% |
0.00% |
-8.19% |
Net Operating Profit after Tax (NOPAT) |
|
76 |
64 |
53 |
-355 |
0.00 |
NOPAT Margin |
|
0.00% |
0.00% |
2,660.00% |
-4,436.25% |
0.00% |
Net Nonoperating Expense Percent (NNEP) |
|
0.00% |
0.00% |
2.50% |
7.39% |
0.00% |
SG&A Expenses to Revenue |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Operating Expenses to Revenue |
|
0.00% |
0.00% |
-3,700.00% |
6,437.50% |
-350.00% |
Earnings before Interest and Taxes (EBIT) |
|
108 |
92 |
76 |
-507 |
72 |
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
296 |
285 |
295 |
-293 |
286 |
Valuation Ratios |
|
- |
- |
- |
- |
- |
Price to Book Value (P/BV) |
|
0.00 |
0.00 |
0.91 |
1.98 |
1.56 |
Price to Tangible Book Value (P/TBV) |
|
0.00 |
0.00 |
14.89 |
4.09 |
3.27 |
Price to Revenue (P/Rev) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Price to Earnings (P/E) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Dividend Yield |
|
0.00% |
0.00% |
0.00% |
0.48% |
2.45% |
Earnings Yield |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Enterprise Value to Invested Capital (EV/IC) |
|
0.00 |
0.00 |
0.97 |
1.55 |
1.31 |
Enterprise Value to Revenue (EV/Rev) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Enterprise Value to EBITDA (EV/EBITDA) |
|
0.00 |
0.00 |
0.00 |
0.00 |
40.92 |
Enterprise Value to EBIT (EV/EBIT) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Enterprise Value to NOPAT (EV/NOPAT) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Enterprise Value to Operating Cash Flow (EV/OCF) |
|
0.00 |
0.00 |
0.00 |
0.00 |
26.54 |
Enterprise Value to Free Cash Flow (EV/FCFF) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Leverage & Solvency |
|
- |
- |
- |
- |
- |
Debt to Equity |
|
0.00 |
0.00 |
1.85 |
0.50 |
0.55 |
Long-Term Debt to Equity |
|
0.00 |
0.00 |
1.84 |
0.49 |
0.53 |
Financial Leverage |
|
0.00 |
0.00 |
1.85 |
0.50 |
0.55 |
Leverage Ratio |
|
0.00 |
0.00 |
3.26 |
1.90 |
1.95 |
Compound Leverage Factor |
|
0.00 |
0.00 |
-3.13 |
2.21 |
0.22 |
Debt to Total Capital |
|
0.00% |
0.00% |
64.91% |
33.46% |
35.54% |
Short-Term Debt to Total Capital |
|
0.00% |
0.00% |
0.30% |
0.89% |
1.26% |
Long-Term Debt to Total Capital |
|
0.00% |
0.00% |
64.60% |
32.57% |
34.28% |
Preferred Equity to Total Capital |
|
0.00% |
0.00% |
0.01% |
0.00% |
0.00% |
Noncontrolling Interests to Total Capital |
|
0.00% |
0.00% |
5.34% |
7.20% |
7.08% |
Common Equity to Total Capital |
|
0.00% |
0.00% |
29.74% |
59.33% |
57.37% |
Debt to EBITDA |
|
0.00 |
0.00 |
0.00 |
0.00 |
11.13 |
Net Debt to EBITDA |
|
0.00 |
0.00 |
0.00 |
0.00 |
10.72 |
Long-Term Debt to EBITDA |
|
0.00 |
0.00 |
0.00 |
0.00 |
10.73 |
Debt to NOPAT |
|
0.00 |
0.00 |
0.00 |
0.00 |
-18.35 |
Net Debt to NOPAT |
|
0.00 |
0.00 |
0.00 |
0.00 |
-17.67 |
Long-Term Debt to NOPAT |
|
0.00 |
0.00 |
0.00 |
0.00 |
-17.70 |
Noncontrolling Interest Sharing Ratio |
|
0.00% |
0.00% |
0.00% |
0.00% |
10.99% |
Liquidity Ratios |
|
- |
- |
- |
- |
- |
Cash Flow Metrics |
|
- |
- |
- |
- |
- |
Free Cash Flow to Firm (FCFF) |
|
0.00 |
0.00 |
-16,344 |
-15,568 |
-14,965 |
Operating Cash Flow to CapEx |
|
0.00% |
129.38% |
0.00% |
121.57% |
92.05% |
Free Cash Flow to Firm to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Operating Cash Flow to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Operating Cash Flow Less CapEx to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Efficiency Ratios |
|
- |
- |
- |
- |
- |
Asset Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Fixed Asset Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
Invested Capital |
|
0.00 |
0.00 |
16,397 |
15,213 |
14,965 |
Invested Capital Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Increase / (Decrease) in Invested Capital |
|
0.00 |
0.00 |
16,397 |
15,213 |
14,965 |
Enterprise Value (EV) |
|
0.00 |
0.00 |
15,881 |
23,621 |
19,561 |
Market Capitalization |
|
4,437 |
4,437 |
4,437 |
17,846 |
13,379 |
Book Value per Share |
|
$0.00 |
$0.00 |
$30.10 |
$39.64 |
$37.63 |
Tangible Book Value per Share |
|
$0.00 |
$0.00 |
$1.84 |
$19.15 |
$17.93 |
Total Capital |
|
0.00 |
0.00 |
16,397 |
15,213 |
14,965 |
Total Debt |
|
0.00 |
0.00 |
10,643 |
5,091 |
5,319 |
Total Long-Term Debt |
|
0.00 |
0.00 |
10,593 |
4,955 |
5,130 |
Net Debt |
|
0.00 |
0.00 |
10,567 |
4,679 |
5,122 |
Capital Expenditures (CapEx) |
|
0.00 |
177 |
0.00 |
153 |
151 |
Net Nonoperating Expense (NNE) |
|
84 |
114 |
133 |
188 |
0.00 |
Net Nonoperating Obligations (NNO) |
|
0.00 |
0.00 |
10,643 |
5,091 |
5,319 |
Total Depreciation and Amortization (D&A) |
|
188 |
193 |
219 |
214 |
214 |
Earnings Adjustments |
|
- |
- |
- |
- |
- |
Adjusted Basic Earnings per Share |
|
$0.00 |
$0.00 |
($0.46) |
($2.44) |
$0.01 |
Adjusted Weighted Average Basic Shares Outstanding |
|
0.00 |
0.00 |
162M |
210M |
228M |
Adjusted Diluted Earnings per Share |
|
$0.00 |
$0.00 |
($0.46) |
($2.44) |
$0.01 |
Adjusted Weighted Average Diluted Shares Outstanding |
|
0.00 |
0.00 |
162M |
210M |
228M |
Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
0.00 |
0.00 |
227.69M |
228.41M |
228.59M |
Normalized Net Operating Profit after Tax (NOPAT) |
|
-854 |
-850 |
-865 |
-869 |
-858 |
Normalized NOPAT Margin |
|
0.00% |
0.00% |
-43,225.00% |
-10,867.50% |
-5,363.75% |
Pre Tax Income Margin |
|
0.00% |
0.00% |
-3,650.00% |
-7,350.00% |
50.00% |
Debt Service Ratios |
|
- |
- |
- |
- |
- |
EBIT to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
NOPAT to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
EBIT Less CapEx to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
NOPAT Less CapEx to Interest Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Payout Ratios |
|
- |
- |
- |
- |
- |
Dividend Payout Ratio |
|
0.00% |
0.00% |
0.00% |
0.00% |
-36.42% |
Augmented Payout Ratio |
|
0.00% |
0.00% |
0.00% |
0.00% |
-38.83% |
Key Financial Trends
The recent financial data for Lineage, Inc. (NASDAQ: LINE) shows a company navigating through a challenging operational landscape but with some stabilizing trends in early 2025. Here are the key takeaways from the last several quarters and years based on income statements, cash flow statements, and balance sheets:
- In Q1 2025, Lineage reported net realized and unrealized capital gains on investments of $16 million, doubling from $8 million in Q3 2024, which positively contributes to non-interest income.
- Net cash from continuing operating activities in Q1 2025 was $139 million, showing operational cash flow strength despite net income being flat at $0 for the quarter.
- The balance sheet as of Q1 2025 shows substantial total assets of approximately $18.8 billion, with $8.6 billion in total common equity, reflecting a solid equity base.
- Lineage’s depreciation and amortization expenses remain high (e.g., $212 million depreciation in Q1 2025), consistent with significant property, equipment, and intangible assets, indicating ongoing capital investment in operations.
- The company generated positive net cash from financing activities in Q1 2025 ($21 million), largely driven by a net issuance of debt which may support growth or refinancing activities.
- Total revenue in Q1 2025 was $16 million, with no interest income or expense reflecting Lineage’s business model not being interest-driven.
- Lineage's total liabilities stood at about $9.1 billion at Q1 2025, with long-term debt around $5.13 billion, indicating leverage that should be monitored but is common for asset-heavy companies.
- The company paid $134 million in dividends in Q1 2025, which may be a positive sign for shareholders but also represents a cash outflow that impacts liquidity.
- Despite positive operating cash flow, net income attributable to common shareholders was flat ($0) in Q1 2025, showing challenges in profitability on an accounting basis after expenses and charges.
- Lineage has faced large restructuring and other special charges in recent quarters (e.g., $15 million restructuring charge and a large negative valuation adjustment of about a billion dollars in Q1 2025), which have weighed on net income and total non-interest expenses.
Trend Summary: Over the past several quarters, Lineage has experienced significant losses, with net income deeply negative through much of 2023 and 2024, reflecting heavy expenses, special charges, and restructuring costs. However, cash flow from operations remains positive, and the company's sizable asset base and equity cushion provide stability. The improved capital gains and an offset in restructuring expenses in early 2025 may point to a potential recovery or more normalized financial performance going forward. Investors should watch how the company manages its leverage, ongoing capital expenditures, and costly restructuring actions, as well as whether it can return consistently to profitability beyond operational cash flow strength.
08/02/25 12:59 PMAI Generated. May Contain Errors.